Mitochondrial energetics in the kidney
Reads0
Chats0
TLDR
Implementing compounds that stimulate mitochondrial biogenesis can restore mitochondrial and renal function in mouse models of AKI and diabetes mellitus and inhibiting the fission protein dynamin 1-like protein (DRP1) might ameliorate ischaemic renal injury by blocking mitochondrial fission.Abstract:
The kidney requires a large number of mitochondria to remove waste from the blood and regulate fluid and electrolyte balance. Mitochondria provide the energy to drive these important functions and can adapt to different metabolic conditions through a number of signalling pathways (for example, mechanistic target of rapamycin (mTOR) and AMP-activated protein kinase (AMPK) pathways) that activate the transcriptional co-activator peroxisome proliferator-activated receptor-γ co-activator 1α (PGC1α), and by balancing mitochondrial dynamics and energetics to maintain mitochondrial homeostasis. Mitochondrial dysfunction leads to a decrease in ATP production, alterations in cellular functions and structure, and the loss of renal function. Persistent mitochondrial dysfunction has a role in the early stages and progression of renal diseases, such as acute kidney injury (AKI) and diabetic nephropathy, as it disrupts mitochondrial homeostasis and thus normal kidney function. Improving mitochondrial homeostasis and function has the potential to restore renal function, and administering compounds that stimulate mitochondrial biogenesis can restore mitochondrial and renal function in mouse models of AKI and diabetes mellitus. Furthermore, inhibiting the fission protein dynamin 1-like protein (DRP1) might ameliorate ischaemic renal injury by blocking mitochondrial fission.read more
Citations
More filters
Journal ArticleDOI
Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment.
TL;DR: More mechanistic studies are needed to better understand the convoluted pathophysiology of S-AKI and to translate these findings into potential treatment strategies and add to the promising pharmacologic approaches being developed and tested in clinical trials.
Journal ArticleDOI
Mitochondrial ROS promote mitochondrial dysfunction and inflammation in ischemic acute kidney injury by disrupting TFAM-mediated mtDNA maintenance.
Meng Zhao,Yizhuo Wang,Ling Li,Shuyun Liu,Chengshi Wang,Yujia Yuan,Guang Yang,Younan Chen,Jingqiu Cheng,Yanrong Lu,Jingping Liu +10 more
TL;DR: In this article, the authors investigated the specific role of mtROS in initiating mitochondrial DNA (mtDNA) damage and inflammation during IRI-AKI, and they found that mt-ROS can promote renal injury by suppressing TFAM-mediated mtDNA maintenance, resulting in decreased mitochondrial energy metabolism and increased cytokine release.
Journal ArticleDOI
Sirtuins in Renal Health and Disease
TL;DR: An overview of the biologic effects of sirtuins and the molecular targets thereof regulating renal physiology is provided, highlighting the key role of SIRT1, SIRT3, and now SIRT6 as potential therapeutic targets.
Journal ArticleDOI
Mitochondrial quality control in kidney injury and repair.
Chengyuan Tang,Juan Cai,Xiao Ming Yin,Joel M. Weinberg,Manjeri A. Venkatachalam,Zheng Dong,Zheng Dong +6 more
TL;DR: The role of mitochondrial quality control mechanisms in kidney injury and repair is discussed and their potential as therapeutic targets are highlighted.
Journal ArticleDOI
Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities
Lucas Opazo-Ríos,Sebastian Mas,Gema Marín-Royo,Sergio Mezzano,Carmen Gomez-Guerrero,Juan Antonio Moreno,Jesús Egido +6 more
TL;DR: This review examines the recent preclinical and clinical research about the potentially harmful effects of lipid effects in the kidney, metabolic markers associated with these mechanisms, major signaling pathways affected, the causes of excessive lipid accumulation, and the types of lipids involved, as well as offers a comprehensive update of therapeutic strategies targeting lipotoxicity.
References
More filters
Journal ArticleDOI
Heart failure and kidney dysfunction: epidemiology, mechanisms and management
TL;DR: Important crosstalk between the heart and kidney is described, with a focus on HF and kidney disease in the acute and chronic settings, and underlying molecular and cellular pathomechanisms in HF, AKI and CKD are discussed in addition to current and future therapeutic approaches.
Journal ArticleDOI
Acute kidney injury: what's the prognosis?
Raghavan Murugan,John A. Kellum +1 more
TL;DR: Emerging evidence suggests that survivors of AKI incur long-term risks for developing chronic kidney disease and end-stage renal disease compared with those without AKI, and further work is required to better understand the pathogenesis ofAKI during critical illness and to develop novel treatments.
Journal ArticleDOI
AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function
Laura L. Dugan,Young Hyun You,Young Hyun You,Sameh S. Ali,Maggie Diamond-Stanic,Maggie Diamond-Stanic,Satoshi Miyamoto,Satoshi Miyamoto,Anne-Emilie Decleves,Anne-Emilie Decleves,Aleksander Andreyev,Tammy Quach,Tammy Quach,San Ly,San Ly,Grigory Shekhtman,William Nguyen,Andre Chepetan,Thuy Le,Lin Wang,Ming Xu,Kacie P. Paik,Agnes B. Fogo,Benoit Viollet,Anne N. Murphy,Frank C. Brosius,Robert K. Naviaux,Kumar Sharma,Kumar Sharma +28 more
TL;DR: It is demonstrated that diabetic kidneys have reduced superoxide and mitochondrial biogenesis and activation of AMPK enhances superoxide production and mitochondrial function while reducing disease activity.
Journal ArticleDOI
Autophagy protects the proximal tubule from degeneration and acute ischemic injury.
Tomonori Kimura,Yoshitsugu Takabatake,Atsushi Takahashi,Jun-ya Kaimori,Isao Matsui,Tomoko Namba,Harumi Kitamura,Fumio Niimura,Taiji Matsusaka,Tomoyoshi Soga,Hiromi Rakugi,Yoshitaka Isaka +11 more
TL;DR: The data suggest that autophagy maintains proximal tubule cell homeostasis and protects against ischemic injury, and may provide a novel therapeutic approach to minimize acute kidney injury and slow CKD progression.
Journal ArticleDOI
Proteolytic Cleavage of Opa1 Stimulates Mitochondrial Inner Membrane Fusion and Couples Fusion to Oxidative Phosphorylation
TL;DR: This work uncovers that real-time proteolytic processing of Opa1 stimulates mitochondrial inner membrane fusion, and this feature is exploited to dynamically couple mitochondrial fusion to cellular metabolism.